Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation

ABSTRACT  Visceral leishmaniasis (VL) has a high fatality rate if not treated; nevertheless, the majority of human infections with the causative agent, Leishmania infantum chagasi, are asymptomatic. Although VL patients often present with increased levels of serum immunoglobulins, the contribution o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luiz Gustavo Gardinassi, Viktoria Dotz, Agnes Hipgrave Ederveen, Roque Pacheco de Almeida, Carlos Henrique Nery Costa, Dorcas Lamounier Costa, Amélia Ribeiro de Jesus, Oleg A. Mayboroda, Gustavo Rocha Garcia, Manfred Wuhrer, Isabel Kinney Ferreira de Miranda Santos
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2014
Materias:
Acceso en línea:https://doaj.org/article/5717c5e5529843b59cce8767a8243131
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5717c5e5529843b59cce8767a8243131
record_format dspace
spelling oai:doaj.org-article:5717c5e5529843b59cce8767a82431312021-11-15T15:47:03ZClinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation10.1128/mBio.01844-142150-7511https://doaj.org/article/5717c5e5529843b59cce8767a82431312014-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01844-14https://doaj.org/toc/2150-7511ABSTRACT  Visceral leishmaniasis (VL) has a high fatality rate if not treated; nevertheless, the majority of human infections with the causative agent, Leishmania infantum chagasi, are asymptomatic. Although VL patients often present with increased levels of serum immunoglobulins, the contribution of antibodies to resistance or progression to disease remains unknown. Effector and regulatory functions of antibodies rely on their interactions with type I and II Fc receptors, and these interactions are tuned by the patterns of antibody Fc N-glycosylation. In view of these facts, we applied a robust method of IgG Fc N-glycopeptide profiling of serum samples from 187 patients with VL, 177 asymptomatic individuals, 116 endemic controls (individuals residing in areas where VL is endemic) and 43 nonendemic controls (individuals living in an area where VL is not endemic). We show that, in comparison to the overall IgG Fc N-glycan profiles of asymptomatic or uninfected healthy individuals, those of patients with VL are profoundly altered. These changes correlate with levels of serum cytokines and the inflammation marker C-reactive protein. We also fitted univariate and multivariate ordinal logistic regression models to demonstrate the ability of IgG Fc N-glycosylation features and immunity regulators present in serum to predict disease severity in VL patients. Importantly, we show that Fc N-glycosylation profiles change after treatment of VL. This study introduces important concepts contributing to the understanding of antibody responses in infections with Leishmania parasites and provides new insights into the pathology of human VL. IMPORTANCE Immunoglobulins (Ig) have been shown to present pro- and anti-inflammatory functions according to the profile of carbohydrates attached to their Fc region. Glycosylation features of serum IgG have been examined in relation to several autoimmune and infectious diseases and provide a mechanistic basis for the protective or pathogenic role of antibodies. Leishmania infantum chagasi is the causative agent of visceral leishmaniasis (VL) in South America, and we show that VL patients produce IgG with patterns of Fc glycans similar to those found in other inflammatory conditions. Specific Fc N-glycosylation features and levels of serum cytokines and C-reactive protein are significantly associated with the development of severe clinical symptoms and, notably, Fc glycosylation changes after treatment. The modifications detected in the N-glycosylation features of IgG Fc from VL patients raise new perspectives on the effector or regulatory role of antibodies in immune responses elicited by infection with Leishmania parasites.Luiz Gustavo GardinassiViktoria DotzAgnes Hipgrave EderveenRoque Pacheco de AlmeidaCarlos Henrique Nery CostaDorcas Lamounier CostaAmélia Ribeiro de JesusOleg A. MayborodaGustavo Rocha GarciaManfred WuhrerIsabel Kinney Ferreira de Miranda SantosAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 5, Iss 6 (2014)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Luiz Gustavo Gardinassi
Viktoria Dotz
Agnes Hipgrave Ederveen
Roque Pacheco de Almeida
Carlos Henrique Nery Costa
Dorcas Lamounier Costa
Amélia Ribeiro de Jesus
Oleg A. Mayboroda
Gustavo Rocha Garcia
Manfred Wuhrer
Isabel Kinney Ferreira de Miranda Santos
Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation
description ABSTRACT  Visceral leishmaniasis (VL) has a high fatality rate if not treated; nevertheless, the majority of human infections with the causative agent, Leishmania infantum chagasi, are asymptomatic. Although VL patients often present with increased levels of serum immunoglobulins, the contribution of antibodies to resistance or progression to disease remains unknown. Effector and regulatory functions of antibodies rely on their interactions with type I and II Fc receptors, and these interactions are tuned by the patterns of antibody Fc N-glycosylation. In view of these facts, we applied a robust method of IgG Fc N-glycopeptide profiling of serum samples from 187 patients with VL, 177 asymptomatic individuals, 116 endemic controls (individuals residing in areas where VL is endemic) and 43 nonendemic controls (individuals living in an area where VL is not endemic). We show that, in comparison to the overall IgG Fc N-glycan profiles of asymptomatic or uninfected healthy individuals, those of patients with VL are profoundly altered. These changes correlate with levels of serum cytokines and the inflammation marker C-reactive protein. We also fitted univariate and multivariate ordinal logistic regression models to demonstrate the ability of IgG Fc N-glycosylation features and immunity regulators present in serum to predict disease severity in VL patients. Importantly, we show that Fc N-glycosylation profiles change after treatment of VL. This study introduces important concepts contributing to the understanding of antibody responses in infections with Leishmania parasites and provides new insights into the pathology of human VL. IMPORTANCE Immunoglobulins (Ig) have been shown to present pro- and anti-inflammatory functions according to the profile of carbohydrates attached to their Fc region. Glycosylation features of serum IgG have been examined in relation to several autoimmune and infectious diseases and provide a mechanistic basis for the protective or pathogenic role of antibodies. Leishmania infantum chagasi is the causative agent of visceral leishmaniasis (VL) in South America, and we show that VL patients produce IgG with patterns of Fc glycans similar to those found in other inflammatory conditions. Specific Fc N-glycosylation features and levels of serum cytokines and C-reactive protein are significantly associated with the development of severe clinical symptoms and, notably, Fc glycosylation changes after treatment. The modifications detected in the N-glycosylation features of IgG Fc from VL patients raise new perspectives on the effector or regulatory role of antibodies in immune responses elicited by infection with Leishmania parasites.
format article
author Luiz Gustavo Gardinassi
Viktoria Dotz
Agnes Hipgrave Ederveen
Roque Pacheco de Almeida
Carlos Henrique Nery Costa
Dorcas Lamounier Costa
Amélia Ribeiro de Jesus
Oleg A. Mayboroda
Gustavo Rocha Garcia
Manfred Wuhrer
Isabel Kinney Ferreira de Miranda Santos
author_facet Luiz Gustavo Gardinassi
Viktoria Dotz
Agnes Hipgrave Ederveen
Roque Pacheco de Almeida
Carlos Henrique Nery Costa
Dorcas Lamounier Costa
Amélia Ribeiro de Jesus
Oleg A. Mayboroda
Gustavo Rocha Garcia
Manfred Wuhrer
Isabel Kinney Ferreira de Miranda Santos
author_sort Luiz Gustavo Gardinassi
title Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation
title_short Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation
title_full Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation
title_fullStr Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation
title_full_unstemmed Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation
title_sort clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc n-glycosylation
publisher American Society for Microbiology
publishDate 2014
url https://doaj.org/article/5717c5e5529843b59cce8767a8243131
work_keys_str_mv AT luizgustavogardinassi clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT viktoriadotz clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT agneshipgraveederveen clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT roquepachecodealmeida clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT carloshenriquenerycosta clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT dorcaslamouniercosta clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT ameliaribeirodejesus clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT olegamayboroda clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT gustavorochagarcia clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT manfredwuhrer clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
AT isabelkinneyferreirademirandasantos clinicalseverityofvisceralleishmaniasisisassociatedwithchangesinimmunoglobulingfcnglycosylation
_version_ 1718427520237305856